Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-26 @ 2:29 AM
Study NCT ID:
NCT02000102
Status:
COMPLETED
Last Update Posted:
2014-11-18
First Post:
2013-11-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
Sponsor:
Stanford University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-26
First Submit QC Date:
None
Study First Post Date:
2013-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-17
Last Update Post Date:
2014-11-18
Last Update Post Date Type:
ESTIMATED